Fourth Quarter 2020 Analyst Presentation Growth Since Going Public
From Continuing Operations
(in millions, except per share data)
Net Sales Operating Income Operating Margin Net Income Diluted EPS
* Average annual increase
1995
GAAP Basis 2020
CAGR
$ 583.6
$ (2.5)
$ 10,119.1 $ 535.3
-0.43%
5.29%
$ (11.0) $ 402.8
$ (0.21) $ 2.81
Special Management Compensation Costs 1995 2020
Reconciling ItemsRestructuring Costs 1995 2020
12.09%
$ -$ $
- -$
-
$ -
n/a (1) 572 bp
$
20.8
$ 32.1
n/a (1)
$ $
19.6 0.37
$ $
- -
$ 24.1
n/a (1)
$ 0.17
(1) In 1995, Operating Income, Net Income and Diluted EPS were negative, and CAGR amounts cannot be calculated. Using 1996 as a base year the CAGR for Operating Income, Net Income and Diluted EPS was 15.08%, 17.15%, and 14.23%, respectively. For 1996, there we no reconciling items on a GAAP to Non-GAAP basis.
Net Gain on Sale of
Investments 1995 2020
1995
Non-GAAP 2020
CAGR
$ 583.6 $ 10,119.1 12.1%
$ 18.3 $ 567.4 14.7%
3.13%
5.61%
10 bps*
$ $
(1.6) $ 8.6 $ 425.3 16.9%
(0.01) $ 0.16 $ 2.97 12.4%
Fourth Quarter 2020 Analyst Presentation Full Year 2020 Financial Highlights
From Continuing Operations
(in millions, except per share data)
Net Sales Operating Income Operating Margin Net Income Diluted EPS
2019
GAAP Basis 2020
Growth
$ 9,985.8
$ 718.3 7.19%
$ 10,119.1 $ 535.3
5.29%
$ 700.7 $ 402.8
$ 4.69 $ 2.81
Restructuring Costs 2019 2020
Reconciling ItemsNet Gain on Sale of Equity Investments 2019 2020
1.3%
-25.5%
$ $ $
14.7
$ 32.1
(190) bp
-42.5%
-40.1%
11.0 0.07
$ 24.1
$ 0.17
$ (186.8) $ (1.6) $ (1.25) $ (0.01)
Tax Credit Related to Animal Health Spin-off
2019
2020
Total Reconciling Items 2019 2020
$ -
$ -
$ 14.7
$
$ (1.3) $ $ (0.01) $
- -
$ (177.1) $
$ (1.19) $
2019
Non-GAAP 2020
Growth
$ $
9,985.8 $ 10,119.1
32.1
733.0 $ 567.4
7.34% 5.61%
1.3% -22.6% (173) bp
22.5 0.16
$ 523.6 $ 425.3 -18.8%
$ 3.51 $ 2.97 -15.4%
Henry Schein, Inc.
Fourth Quarter 2020 Analyst Presentation Q4 2020 - Financial Highlights
From Continuing Operations
(in millions, except per share data)
Reconciling Items
2019 Restructuring Credits and 2020
Q4 2019
GAAP Basis
Q4 2020
Growth
Net Sales Operating Income Operating Margin Net Income Diluted EPS
$ 2,668.9 $
3,165.7 18.6%
$ 196.3 $ 7.36%
181.2 -7.7%
5.72% (164) bp
Restructuring Costs 2019
Net Gain on Sale of Equity Investments
Non-GAAP
2020
2019
2020
Q4 2019
Q4 2020
Growth
$ 2,668.9 $
3,165.7 18.6%
$
(1.1) $ 4.4
$ 330.6 $
141.9 0.99
-57.1% -56.0%
$ $
(0.8) $ 3.3
$ 2.25 $
(0.01) $ 0.02
$ 195.3 $ 7.32%
185.6 -5.0%
5.86% (146) bp
$ $
(186.8) $ (1.27) $
(1.6) (0.01)
$ 143.0 $
143.6 0.4%
$ 0.97 $
1.00 3.1%
Henry Schein, Inc.
Fourth Quarter 2020 Analyst Presentation Q4 2020 - Financial Highlights
From Continuing Operations
(in millions, except per share data)
Net Sales Operating Income Operating Margin
GAAP BasisQ4 2019
Q4 2020
Growth
$ 2,668.9 $
$ 196.3 $ 7.36%
3,165.7 18.6%
181.2 -7.7%
5.72% (163) bp
Reconciling Items
2019 Restructuring Credits and 2020
Q4 2019 Q4 2020
Non-GAAPQ4 2019
Q4 2020
Growth
$
- (1.1)
$
- 4.4
$ 2,668.9 $
$ 195.3 $ 7.32%
3,165.7 18.6%
185.6 -5.0%
5.86% (146) bp
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Henry Schein Inc. published this content on 17 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 February 2021 13:35:06 UTC.